Literature DB >> 23179366

Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients.

Hiroaki Saito1, Seigo Takaya, Tomohiro Osaki, Masahide Ikeguchi.   

Abstract

BACKGROUND: Immune cells undergo extensive apoptosis in patients with cancer, which may be related to immune evasion by cancerous cells. The present study was designed to investigate the relationship between natural killer (NK) cell apoptosis and Fas expression in gastric cancer patients.
METHODS: NK cell apoptosis and Fas expression were evaluated by multicolor flow cytometry. Soluble Fas ligand (sFasL) was quantitated by enzyme-linked immunosorbent assay.
RESULTS: The frequency of apoptotic NK cells in gastric cancer patients was significantly higher than in normal controls (p = 0.0016). Moreover, their frequency was related to the progression of gastric cancer. Fas-positive NK cells were significantly more common in gastric cancer patients compared with normal controls (p = 0.034). Furthermore, Fas expression was closely related to the frequency of NK cell apoptosis (r = 0.6, p < 0.0001). The frequency of tumor-infiltrating NK cell apoptosis was significantly higher than that of circulating NK cell apoptosis (p = 0.035). Furthermore, Fas-positive NK cells in gastric cancer tissues occurred significantly more often than in peripheral blood (p = 0.029). FasL concentration in gastric cancer patients was lower than that in normal controls, and the difference tended to be significant (p = 0.057). Apoptotic circulating NK cells significantly decreased after surgery compared to before surgery (p = 0.023). Furthermore, Fas expression on circulating NK cells also significantly decreased after surgery compared with before surgery (p = 0.021).
CONCLUSIONS: Upregulation of Fas expression on NK cells is related to increased apoptosis of circulating NK cells in gastric cancer patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179366     DOI: 10.1007/s10120-012-0210-1

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  35 in total

Review 1.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 2.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

Review 3.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

4.  Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis.

Authors:  H Takeuchi; Y Maehara; E Tokunaga; T Koga; Y Kakeji; K Sugimachi
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

5.  Significance of serum soluble Fas ligand in patients with bladder carcinoma.

Authors:  Y Mizutani; F Hongo; N Sato; O Ogawa; O Yoshida; T Miki
Journal:  Cancer       Date:  2001-07-15       Impact factor: 6.860

6.  Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.

Authors:  B R Gastman; Y Atarshi; T E Reichert; T Saito; L Balkir; H Rabinowich; T L Whiteside
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

7.  Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells.

Authors:  M E Nunn; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1979-04       Impact factor: 13.506

8.  Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.

Authors:  Thomas Bauernhofer; Iris Kuss; Brent Henderson; Andrew S Baum; Theresa L Whiteside
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

9.  Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects.

Authors:  Christophe Borg; Magali Terme; Julien Taïeb; Cédric Ménard; Caroline Flament; Caroline Robert; Koji Maruyama; Hiro Wakasugi; Eric Angevin; Kris Thielemans; Axel Le Cesne; Véronique Chung-Scott; Vladimir Lazar; Isabelle Tchou; Florent Crépineau; François Lemoine; Jacky Bernard; Jonhantan A Fletcher; Ali Turhan; Jean-Yves Blay; Alain Spatz; Jean-François Emile; Michael C Heinrich; Salah Mécheri; Thomas Tursz; Laurence Zitvogel
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.

Authors:  N L Vujanovic; R B Herberman; A A Maghazachi; J C Hiserodt
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Gastric cancer and the epoch of immunotherapy approaches.

Authors:  Elena Niccolai; Antonio Taddei; Domenico Prisco; Amedeo Amedei
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 2.  Mechanism of interaction between autophagy and apoptosis in cancer.

Authors:  Shreya Das; Nidhi Shukla; Shashi Shekhar Singh; Sapana Kushwaha; Richa Shrivastava
Journal:  Apoptosis       Date:  2021-09-12       Impact factor: 4.677

3.  Increased risk of developing digestive tract cancer in subjects carrying the PLCE1 rs2274223 A>G polymorphism: evidence from a meta-analysis.

Authors:  Xunlei Zhang; Yangmei Zhang; Dongying Gu; Chunxiang Cao; Qi Zhang; Zhi Xu; Yongling Gong; Jinfei Chen; Cuiju Tang
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

Review 4.  Role of Exosomes Released by Dendritic Cells and/or by Tumor Targets: Regulation of NK Cell Plasticity.

Authors:  Katrin S Reiners; Juliane Dassler; Christoph Coch; Elke Pogge von Strandmann
Journal:  Front Immunol       Date:  2014-03-07       Impact factor: 7.561

5.  Significance of CD47 expression in gastric cancer.

Authors:  Tomoya Sudo; Yusuke Takahashi; Genta Sawada; Ryutaro Uchi; Koshi Mimori; Yoshito Akagi
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

Review 6.  Exosome-Based Cell-Cell Communication in the Tumor Microenvironment.

Authors:  Joana Maia; Sergio Caja; Maria Carolina Strano Moraes; Nuno Couto; Bruno Costa-Silva
Journal:  Front Cell Dev Biol       Date:  2018-02-20

Review 7.  Immunotherapy for Gastric Cancer: Time for a Personalized Approach?

Authors:  Riccardo Dolcetti; Valli De Re; Vincenzo Canzonieri
Journal:  Int J Mol Sci       Date:  2018-05-29       Impact factor: 5.923

Review 8.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

Review 9.  Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy.

Authors:  Vinod Vijay Subhash; Mei Shi Yeo; Woei Loon Tan; Wei Peng Yong
Journal:  J Immunol Res       Date:  2015-10-22       Impact factor: 4.818

10.  Similar blood-borne DNA methylation alterations in cancer and inflammatory diseases determined by subpopulation shifts in peripheral leukocytes.

Authors:  H Li; T Zheng; B Chen; G Hong; W Zhang; T Shi; S Li; L Ao; C Wang; Z Guo
Journal:  Br J Cancer       Date:  2014-06-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.